Novartis Investigative Site

Alytus LT-62386

0 studies enrolling now · 3 studies all time

What they study most

Atherosclerosis, Hypertension, Primary Prevention of Atherosclerotic Cardiovascular Disease

Studies at this site

• A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients. — Running, not enrolling
• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) — Completed
• Efficacy and Safety of LCZ696A in Patients With Essential Hypertension — Completed